At a recent event at the University of Akron School of Law, Professor Erika Lietzan spoke about what she called the “assault on drug patents,” including patent reform activity in Congress as well as proposals to prevent drug companies from patenting any changes or improvements to their drugs after approval (so called “one and done” proposals). She explained that medical…
Unit: Center for Intellectual Property and Entrepreneurship ⋅ Page 3
Professor Lietzan’s Research Analyzes Patent Terms for New Medicine
A recent article in Bloomberg Law, U.S. Patent System Crimps Drug Innovation for Toughest Diseases, looks at the research of Professor Erika Lietzan and Kristina M.L. Acri about how the development of new drugs is affected by the U.S. patent system. Their research will be published in a forthcoming article. Their empirical research looked at 642 approved drugs to determine…
Professor Myers Presents at SEALS Conference
Professor Gary Myers served as a speaker on three programs at the Southeastern Association of Law Schools (SEALS) Annual Meeting in Boca Raton, Florida. He spoke on a panel regarding a “Supreme Court and Legislative Update (Business and Regulatory Issues),” on a discussion group where the topic was “Faculty Development Deans—Leadership, Promotion, and Mentorship,” and on a Free Speech Workshop…
Professor Myers Speaks at Free Speech Discussion Forum in Hungary
Professor Gary Myers served as a speaker on “Local Media Coverage in the Modern Age: Modifying Antitrust and Competition Policy” at the Free Speech Discussion Forum held in Budapest, Hungary in June 2019. The forum was sponsored by Pázmány Péter Catholic University Faculty of Law (Hungary), the University of Luxembourg’s Faculty of Law, Economics and Finance, the University of Paris…
Professor Myers Shares 2019 U.S. Supreme Court Highlights with Missouri Bar and SEALS
Professor Gary Myers discussed “2019 United States Supreme Court Highlights (2018-2019 Term)” as a speaker/panelist for the Missouri Bar as part of the MobarCLE program, presented to Bar members by teleconference on August 7. He focused on cases related to antitrust, the commerce clause, intellectual property, and the U.S. census. He also spoke on a panel, “Supreme Court and Legislative…
Professor Lietzan testifies before the U.S. House of Representatives Judiciary Committee
Professor Erika Lietzan testified before the House of Representatives Judiciary Committee on July 27, 2017 in a hearing addressing Antitrust Concerns and the FDA Approval Process. Testimony to House of Representatives Judiciary Committee –…